Literature DB >> 18854483

Candida parapsilosis, an emerging fungal pathogen.

David Trofa1, Attila Gácser, Joshua D Nosanchuk.   

Abstract

SUMMARY: Candida parapsilosis is an emerging major human pathogen that has dramatically increased in significance and prevalence over the past 2 decades, such that C. parapsilosis is now one of the leading causes of invasive candidal disease. Individuals at the highest risk for severe infection include neonates and patients in intensive care units. C. parapsilosis infections are especially associated with hyperalimentation solutions, prosthetic devices, and indwelling catheters, as well as the nosocomial spread of disease through the hands of health care workers. Factors involved in disease pathogenesis include the secretion of hydrolytic enzymes, adhesion to prosthetics, and biofilm formation. New molecular genetic tools are providing additional and much-needed information regarding C. parapsilosis virulence. The emerging information will provide a deeper understanding of C. parapsilosis pathogenesis and facilitate the development of new therapeutic approaches for treating C. parapsilosis infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854483      PMCID: PMC2570155          DOI: 10.1128/CMR.00013-08

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  299 in total

1.  Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.

Authors:  Frank C Odds; Mary Motyl; Roberto Andrade; Jacques Bille; Emilia Cantón; Manuel Cuenca-Estrella; Amanda Davidson; Christian Durussel; David Ellis; Elyse Foraker; Annette W Fothergill; Mahmoud A Ghannoum; Robert A Giacobbe; Miguel Gobernado; Rosemary Handke; Michel Laverdière; Wendy Lee-Yang; William G Merz; Luis Ostrosky-Zeichner; Javier Pemán; Sophia Perea; John R Perfect; Michael A Pfaller; Laurie Proia; John H Rex; Michael G Rinaldi; Juan-Luis Rodriguez-Tudela; Wiley A Schell; Christine Shields; Deanna A Sutton; Paul E Verweij; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Cloning and characterization of Sapp2p, the second aspartic proteinase isoenzyme from Candida parapsilosis.

Authors:  Michaela Merkerová; Jirí Dostál; Martin Hradilek; Iva Pichová; Olga Hrusková-Heidingsfeldová
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

3.  Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary.

Authors:  Sándor Kocsubé; Mónika Tóth; Csaba Vágvölgyi; Ilona Dóczi; Miklós Pesti; István Pócsi; Judit Szabó; János Varga
Journal:  J Med Microbiol       Date:  2007-02       Impact factor: 2.472

4.  Prevalence of Candida parapsilosis in the oral cavities of infants in Spain.

Authors:  I Contreras; J Pontón; G Quindós
Journal:  Clin Infect Dis       Date:  1994-03       Impact factor: 9.079

5.  Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality.

Authors:  H Alonso-Valle; O Acha; J D García-Palomo; C Fariñas-Alvarez; C Fernández-Mazarrasa; M C Fariñas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-22       Impact factor: 3.267

6.  Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak.

Authors:  S F Welbel; M M McNeil; R J Kuykendall; T J Lott; A Pramanik; R Silberman; A D Oberle; L A Bland; S Aguero; M Arduino; S Crow; W R Jarvis
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

7.  Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis.

Authors:  F De Bernardis; S Arancia; L Morelli; B Hube; D Sanglard; W Schäfer; A Cassone
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

8.  Incidence and significance of candiduria.

Authors:  P K Goldberg; P J Kozinn; G J Wise; N Nouri; R B Brooks
Journal:  JAMA       Date:  1979-02-09       Impact factor: 56.272

9.  Evidence for aneuploidy and recombination in the human commensal yeast Candida parapsilosis.

Authors:  Ruth E Fundyga; Randall J Kuykendall; Wendy Lee-Yang; Timothy J Lott
Journal:  Infect Genet Evol       Date:  2004-03       Impact factor: 3.342

10.  Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.

Authors:  Valda Teixeira Figueiredo; Daniel de Assis Santos; Maria Aparecida Resende; Júnia Soares Hamdan
Journal:  Mycopathologia       Date:  2007-06-06       Impact factor: 2.574

View more
  220 in total

1.  Evidence for the presence of proteolytically active secreted aspartic proteinase 1 of Candida parapsilosis in the cell wall.

Authors:  Zuzana Vinterová; Miloslav Sanda; Jiří Dostál; Olga Hrušková-Heidingsfeldová; Iva Pichová
Journal:  Protein Sci       Date:  2011-11-01       Impact factor: 6.725

2.  Comparison of antifungal activities of gentian violet and povidone-iodine against clinical isolates of Candida species and other yeasts: a framework to establish topical disinfectant activities.

Authors:  Shigemi Kondo; Yoko Tabe; Toshihiko Yamada; Shigeki Misawa; Toyoko Oguri; Akimichi Ohsaka; Takashi Miida
Journal:  Mycopathologia       Date:  2011-08-12       Impact factor: 2.574

3.  MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units.

Authors:  G Pulcrano; E Roscetto; V D Iula; D Panellis; F Rossano; M R Catania
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-30       Impact factor: 3.267

4.  Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.

Authors:  Olivier Lortholary; Marie Desnos-Ollivier; Karine Sitbon; Arnaud Fontanet; Stéphane Bretagne; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

5.  Adhesins in Candida parapsilosis: Understudied players in virulence.

Authors:  Attila Gacser
Journal:  Virulence       Date:  2015-12-29       Impact factor: 5.882

6.  Antimicrobial Activity and DNA/BSA Binding Affinity of Polynuclear Silver(I) Complexes with 1,2-Bis(4-pyridyl)ethane/ethene as Bridging Ligands.

Authors:  Sonja Ž Đurić; Sandra Vojnovic; Tina P Andrejević; Nevena Lj Stevanović; Nada D Savić; Jasmina Nikodinovic-Runic; Biljana Đ Glišić; Miloš I Djuran
Journal:  Bioinorg Chem Appl       Date:  2020-04-14       Impact factor: 7.778

Review 7.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

8.  In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

Authors:  He Wang; Meng Xiao; Sharon C-A Chen; Fanrong Kong; Zi-Yong Sun; Kang Liao; Juan Lu; Hai-Feng Shao; Yan Yan; Hong Fan; Zhi-Dong Hu; Yun-Zhuo Chu; Tie-Shi Hu; Yu-Xing Ni; Gui-Ling Zou; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Hemolytic factor production by clinical isolates of Candida species.

Authors:  Daniel Favero; Luciana Furlaneto-Maia; Emanuele J G França; Helena Peggau Góes; Marcia Cristina Furlaneto
Journal:  Curr Microbiol       Date:  2013-09-19       Impact factor: 2.188

10.  Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.

Authors:  Plinio Trabasso; Tetsuhiro Matsuzawa; Renata Fagnani; Yasunori Muraosa; Kenichiro Tominaga; Mariangela Ribeiro Resende; Katsuhiko Kamei; Yuzuru Mikami; Angelica Zaninelli Schreiber; Maria Luiza Moretti
Journal:  Mycopathologia       Date:  2014-12-07       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.